©2024 Stanford Medicine
A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Recruiting
I'm InterestedTrial ID: NCT02954094
Purpose
TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual
clinical practice. TARGET-HCC will create a research registry of participants with HCC within
academic and community real-world practices in order to assess the safety and effectiveness
of the entire spectrum of current and future therapies across diverse populations.
Official Title
A Longitudinal Observational Study of the Natural History and Management of Patients With Hepatocellular Carcinoma
Stanford Investigator(s)
Paul Kwo
Professor of Medicine (Gastroenterology and Hepatology)
Eligibility
Inclusion Criteria:
1. Male or female patients, age ≥18 years
2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC
cholangiocarcinoma may be included; patients who are candidates for surgical and
non-surgical treatment, as well as those being followed without specific HCC therapy
may be included)
Exclusion Criteria:
1. Inability to provide written informed consent
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Swati Toppo
650-497-4151